Table 3 Changes from baseline scores for patient reported outcomes (PRO)
Change (n = 317) | |||
|---|---|---|---|
Discharge - Baseline | 3 months – Baseline | 6 months - Baseline | |
HAQ | -0.09 (-0.13 to -0.2) | -0.04 (-0.14 to 0.03) | 0.03 (-0.09 to 0.03) |
SF-36 PCS | 1.1 (0.1 to 2.1) | 0.4 (-0.6 to 1.4) | 0.6 (-0.5 to 1.6) |
SF36 MCS | 2.1 (0.6 to 3.5) | 2.3 (0.9 to 3.8) | 2.3 (0.8 to 3.8) |
Pain | -9.4 (-12.5 to -6.4) | -5.0 (-8.1 to -1.9) | -3.8 (-7.0 to -0.7) |
Fatigue | -5.1 (-8.3 to -1.8) | -3.5 (-6.9 to -0.2) | -3.0 (-6.3 to 0.4) |
Patient global | -8.9 (-12.1 to -5.7) | -2.5 (-5.7 to 0.7) | -2.0 (-5.3 to 1.2) |
SES pain | 3.28 (1.1 to 5.5) | -0.1 (-2.4 to 2.1) | -0.1 (-2.4 to 2.2) |
SES symptoms | 4.1 (2.1 to 6.0) | 1.8 (-0.1 to 3.8) | -0.1 (-2.1 to 1.9) |
RADAI | -0.66 (-0.90 to -0.41) | -0.11 (-0.37 to 0.14) | -0.07 (-0.33 to 0.18) |
SF6D | 0.028 (0.014 to 0.042) | 0.027 (0.012 to 0.041) | 0.028 (0.014 to 0.042) |